Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo en Inglés | IMSEAR | ID: sea-140040

RESUMEN

An extremely effective way of preventing damage to and enhancing treatment of dental hard tissues and restorations would be to ''de-programme'' the muscles responsible for excessive destructive forces and other gnathological-related diseases. The new paradigm is the intramuscular injection of Botulinum toxin type A (BOTOX) into the affected muscles. It is a natural protein produced by anaerobic bacterium, Clostridium botulinum. The toxin inhibits the release of acetylcholine (ACH), a neurotransmitter responsible for the activation of muscle contraction and glandular secretion, and its administration results in reduction of tone in the injected muscle. There are seven distinct serotypes of Botulinum toxin, viz., A, B, C, D, E, F, and G, which differ in their potency, duration of action, and cellular target sites. This paper describes the different applications of BOTOX in dentistry.


Asunto(s)
Toxinas Botulínicas Tipo A/administración & dosificación , Fracaso de la Restauración Dental , Dolor Facial/tratamiento farmacológico , Dolor Facial/etiología , Humanos , Músculos Masticadores/efectos de los fármacos , Músculos Masticadores/fisiopatología , Enfermedades Musculoesqueléticas/complicaciones , Enfermedades Musculoesqueléticas/tratamiento farmacológico , Fármacos Neuromusculares/administración & dosificación , Trastornos de la Articulación Temporomandibular/complicaciones , Trastornos de la Articulación Temporomandibular/tratamiento farmacológico
2.
Indian J Dermatol Venereol Leprol ; 2008 Sep-Oct; 74(5): 513-5
Artículo en Inglés | IMSEAR | ID: sea-52766
3.
Indian J Dermatol Venereol Leprol ; 2006 Jan-Feb; 72(1): 86
Artículo en Inglés | IMSEAR | ID: sea-52959
4.
Indian J Dermatol Venereol Leprol ; 2005 May-Jun; 71(3): 192-4
Artículo en Inglés | IMSEAR | ID: sea-52976

RESUMEN

Disabling pansclerotic morphea is a rare atrophying and sclerosing disorder of the subcutaneous tissue, muscle and bone. It is characterized by atrophy of the skin, subcutaneous fat, muscle and bone involving half of the face. In some patients the atrophic lesions extend to involve the ipsilateral or contralateral upper and lower limbs with radiological evidence of hemiatrophy. The patients may present with arthralgia, convulsions or cramps. We report a case of a woman with deformity of face, and left upper and lower limbs that had started as an indurated plaque on the left half of forehead at the age of 5 years and had gradually enlarged, followed by the development of atrophic changes in left eye. The case is being reported in view of its rare occurrence.


Asunto(s)
Adulto , Contractura/diagnóstico , Articulación del Codo/fisiopatología , Hemiatrofia Facial/diagnóstico , Femenino , Humanos , Pronóstico , Medición de Riesgo , Esclerodermia Localizada/diagnóstico , Índice de Severidad de la Enfermedad
5.
Indian J Dermatol Venereol Leprol ; 2005 Mar-Apr; 71(2): 134-5
Artículo en Inglés | IMSEAR | ID: sea-52903
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA